Placing the Cell and Gene Therapy Catapult at the forefront of translational research: an interview with Jonathan Appleby
In this interview, Jonathan Appleby discusses his appointment as the new Chief Scientific Officer of the Cell and Gene Therapy Catapult.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>